Liraglutide 6mg

Research Applications & Mechanisms

Mechanism of Action

GLP-1 Receptor Agonist

Liraglutide is a GLP-1 receptor agonist with a 13-hour half-life, requiring daily administration. Originally developed for type 2 diabetes (Victoza), it's also approved for weight management (Saxenda). This daily peptide provides researchers with a shorter-acting alternative to weekly GLP-1 agonists.

Primary Research Areas

• Glucose metabolism research
• Appetite regulation studies
• Weight management research
• Cardiovascular metabolic effects
• Beta-cell function studies

Pharmacokinetic Profile

• Half-Life: 13 hours
• Dosing Frequency: Daily
• Purity: 99.1%+ (HPLC verified)

Technical Specifications

Product Information

Storage Conditions

• Lyophilized Storage: -20°C to -80°C
• Lyophilized Stability: 24+ months at -20°C
• Reconstituted Storage: 2-8°C (refrigerated)
• Reconstituted Stability: 28 days at 2-8°C

Package Contents

• 1 x Liraglutide 6mg vial (lyophilized)
• Certificate of Analysis (COA)
• HPLC chromatogram
• Reconstitution guide
• Storage instructions